CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ELR SCAR project aims to validate an elastin-like hydrogel designed to prevent scar tissue formation in the heart after a heart attack. This innovative treatment seeks to improve patient outcomes by addressing the limitations of current post-myocardial infarction therapies.
The ELR SCAR project aims to complete preclinical validation of a novel biomaterial, an elastin-like recombinant (ELR) hydrogel, to prevent scar tissue formation in the heart following myocardial infarction (MI), commonly called a heart attack. MI is the endpoint of ischaemic heart disease (IHD).
In Europe, the highest rates of IHD worldwide equal ~26.5 million patients.
Standards of care interventions after MI have serious limitations in treatment efficacy (many patients are still at risk of de…
UNIVERSITY OF GALWAY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Valladolid
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Ireland, Galway
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Lithuania, Kaunas
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, LORRACH
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
